Phone
Email
ClinicalTrials.gov URL
Acknowledgement
N/A
EA Page
ILiAD Biotechnologies
EA Policies for Single Patient
ILiAD is committed to developing safe and effective vaccines, with a goal to providing our next generation vaccines as soon as possible through efficient vaccine development. At this time, ILiAD’s vaccines are in the investigational phase and not yet marketed. ILiAD does not have an expanded access program.
EA Policies for Disease / Category